SVA vs VRTX: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Vertex Pharmaceuticals Inc in 2026
SVA
Sinovac Biotech Ltd
$6.47
VRTX
Vertex Pharmaceuticals Inc
$435.65
Key Metrics Comparison
| Metric | SVA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $642.44M | $112.35B | VRTX |
| P/E Ratio | 6.66 | 28.81 | SVA |
| EPS (TTM) | $0.97 | $15.33 | VRTX |
| Revenue Growth | 3.0% | 0.1% | SVA |
| Gross Margin | 86.8% | 53.7% | SVA |
Analyze SVA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or VRTX a better investment?
Comparing SVA and VRTX: Sinovac Biotech Ltd has a market cap of $642.44M while Vertex Pharmaceuticals Inc has $112.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and VRTX?
SVA (Sinovac Biotech Ltd) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or VRTX?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 28.8x).
Which is growing faster: SVA or VRTX?
SVA has higher revenue growth at 3.0% vs 0.1% for VRTX.
Which company is more profitable: SVA or VRTX?
Sinovac Biotech Ltd (SVA) has higher gross margins at 86.8% compared to 53.7% for VRTX.
Which is the larger company: SVA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.35B compared to $642.44M for SVA.
Should I buy SVA or VRTX in 2026?
Both SVA and VRTX have investment merit. SVA trades at $6.47 while VRTX trades at $435.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and VRTX stock?
Key differences: Market Cap ($642.44M vs $112.35B), P/E Ratio (6.7x vs 28.8x), Revenue Growth (3.0% vs 0.1%), Gross Margin (86.8% vs 53.7%).